Rheumatology

Biologic DMARDs have shown comparable effectiveness and drug retention in psoriatic arthritis, with partially distinct response patterns by class.

Joint distribution has been linked to progression in undifferentiated arthritis, with combined hand and large-joint involvement signalling higher risk.

Autoimmune rheumatic diseases have been linked to a higher risk of Long COVID, with certain therapies and clinical factors also linked.

Treat-to-target therapy in early rheumatoid arthritis has been associated with favourable long-term clinical, structural and functional outcomes.

A non-invasive optical imaging method has been associated with skin fibrosis in systemic sclerosis, supporting its use as an outcome measure.

Early diagnosis of axial spondyloarthritis has been associated with less long-term spinal structural damage in a Swiss registry cohort.

A prospective study found higher pregnancy complication rates in women with lupus who were not in remission, particularly among high-risk patients.

Peresolimab has been linked to fewer PD-1 high-expressing CD4 T cells and neutrophils, and reduced inflammatory signalling in rheumatoid arthritis.